Document Detail


Costs of Addressing Heroin Addiction in Malaysia and 32 Comparable Countries Worldwide.
MedLine Citation:
PMID:  22091732     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE: Develop and apply new costing methodologies to estimate costs of opioid dependence treatment in countries worldwide. DATA SOURCES/STUDY SETTING: Micro-costing methodology developed and data collected during randomized controlled trial (RCT) involving 126 patients (July 2003-May 2005) in Malaysia. Gross-costing methodology developed to estimate costs of treatment replication in 32 countries with data collected from publicly available sources. STUDY DESIGN: Fixed, variable, and societal cost components of Malaysian RCT micro-costed and analytical framework created and employed for gross-costing in 32 countries selected by three criteria relative to Malaysia: major heroin problem, geographic proximity, and comparable gross domestic product (GDP) per capita. PRINCIPAL FINDINGS: Medication, and urine and blood testing accounted for the greatest percentage of total costs for both naltrexone (29-53 percent) and buprenorphine (33-72 percent) interventions. In 13 countries, buprenorphine treatment could be provided for under $2,000 per patient. For all countries except United Kingdom and Singapore, incremental costs per person were below $1,000 when comparing buprenorphine to naltrexone. An estimated 100 percent of opiate users in Cambodia and Lao People's Democratic Republic could be treated for $8 and $30 million, respectively. CONCLUSIONS: Buprenorphine treatment can be provided at low cost in countries across the world. This study's new costing methodologies provide tools for health systems worldwide to determine the feasibility and cost of similar interventions.
Authors:
Jennifer Prah Ruger; Marek Chawarski; Mahmud Mazlan; Craig Luekens; Nora Ng; Richard Schottenfeld
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-18
Journal Detail:
Title:  Health services research     Volume:  -     ISSN:  1475-6773     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-11-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0053006     Medline TA:  Health Serv Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© Health Research and Educational Trust.
Affiliation:
Yale School of Public Health, Health Policy and Administration, New Haven, CT.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPAR? in high-fat-diet f...
Next Document:  Exposure to acute stress is associated with attenuated sweet taste.